Rakesh Verma

Rakesh Verma has a diverse work experience in the biotechnology and pharmaceutical industry. Rakesh is currently serving as the Senior Vice President R&D and Founder at Sastra cell therapy, a position they began in February 2021. Prior to this, they were a Co-Founder and Chief Development Officer (CDO) at Diadem Biotherapeutics from January 2020 to December 2020. In addition, Rakesh has worked as an Independent Consultant - CDO, provided advisory roles at Berkeley SkyDeck, Dynomics, and Novateur Ventures Inc., and held leadership positions at ARMO BioSciences, Eli Lilly and Company, and Achelois oncology. Rakesh also has academic experience at Yale University, where they served as a PI in Oncology/Immunology and as an Instructor for undergraduate research.

Rakesh Verma has a diverse education history. Rakesh completed a Fellowship in Hematology Oncology at Yale University. Rakesh also pursued a field of study in Entrepreneurship/Entrepreneurial Studies at the Massachusetts Institute of Technology, although it is not specified whether they obtained a degree there. Rakesh obtained a Doctor of Philosophy (PhD) in Medical Oncology from the All India Institute of Medical Sciences. Additionally, they earned a Master of Science (MS) degree in Toxicology from Jamia Hamdard. Rakesh Verma holds a Bachelor's degree in Biology/Biological Sciences, General from Delhi University. Rakesh also earned a Master of Business Administration (MBA) degree in Business Administration, Management and Operations from Symbiosis Centre for Distance Learning. Furthermore, they hold a Bachelor's degree in Computer Science from Indira Gandhi National Open University. Besides their academic education, Rakesh Verma has obtained certifications such as "Finance Foundations: Business Valuation" from LinkedIn and "Credential check - ABMG Certification Examination" from the American Board of Medical Genetics and Genomics.